1887
Research article Open Access
Like 0

Abstract

Screening of undocumented migrants or refugees for hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections has been offered free of charge and free from bureaucratic procedures since 2012 at four primary-level clinical centres in Naples and Caserta, Italy. Of 926 undocumented migrants and refugees visiting one of the primary-level clinical centres from January 2012 to June 2013, 882 (95%) were screened for hepatitis B surface antigen (HBsAg), total hepatitis B core antibody (anti-HBc) and antibodies against HCV and HIV. Of the 882 individuals enrolled, 78 (9%) were HBsAg positive, 35 (4%) anti-HCV positive and 11 (1%) anti-HIV positive (single infections); seven (1%) had more than one infection (three were HBsAg positive). Of the 801 HBsAg-negative patients, 373 (47%) were anti-HBc positive. The HBsAg-positivity rate was high (14%; 62/444) in individuals from sub-Saharan Africa and intermediate in those from eastern Europe (6%; 12/198), northern Africa (2%; 2/80) and Bangladesh, India, Pakistan and Sri Lanka (the ‘India-Pakistan area’) (3%; 4/126). Anti-HCV was detected in 9/126 (7%) individuals originating from the India-Pakistan area, in 12/198 (6%) from eastern Europe, in 17/444 (4%) from sub-Saharan and in 2/80 (2%) from northern Africa. The HBV, HCV and HIV infections in the undocumented migrants and refugees screened serve as a reminder to the Italian healthcare authorities to carry out extensive screening and educational programmes for these populations.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2015.20.35.30009
2015-09-03
2017-11-22
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2015.20.35.30009
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/20/35/eurosurv-20-30009-2.html?itemId=/content/10.2807/1560-7917.ES.2015.20.35.30009&mimeType=html&fmt=ahah

References

  1. Williams R. Global challenges in liver disease. Hepatology. 2006;44(3):521-6.  https://doi.org/10.1002/hep.21347  PMID: 16941687 
  2. World Health Organization (WHO). Countries. Geneva: WHO. [Accessed 22 Aug 2015]. Available from: http://www.who.int/countries/en/
  3. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015. pii: S0140-6736(15)61412-X. doi: 10.1016/S0140-6736(15)61412-X. [Epub ahead of print].
  4. Stasi C, Silvestri C, Voller F, Cipriani F. The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine. J Infect Public Health. 2015. pii: S1876-0341(15)00101-X. doi: https://doi.org/10.1016/j.jiph.2015.05.004  [Epub ahead of print].
  5. van Sighem A, Nakagawa F, De Angelis D, Quinten C, Bezemer D, de Coul EO, et al. Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data. Epidemiology. 2015;26(5):653-60.  https://doi.org/10.1097/EDE.0000000000000324  PMID: 26214334 
  6. Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258-71.  https://doi.org/10.1016/S0140-6736(14)60164-1  PMID: 24907868 
  7. Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, Ferrigno L, et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J Med Virol. 2005;75(4):522-7.  https://doi.org/10.1002/jmv.20313  PMID: 15714480 
  8. Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio PLItalian Hospitals’ Collaborating Group. Chronic hepatitis B in Italy: new features of an old disease--approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. Clin Infect Dis. 2008;46(1):110-3.  https://doi.org/10.1086/524074  PMID: 18171224 
  9. Centro Operativo AIDS [(AIDS Operative Center] (COA). Notiziario dell’istituto Superiore di Sanità. Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2013. [News of the National Institute of Health on the new diagnosis of HIV infection and AIDS in Italy at 31 December 2013]. 2014;27(9 Suppl 1);1-47. Italian. Available from: http://www.iss.it/binary/ccoa/cont/ONLINE_6_COA_2014.pdf
  10. McCarthy AE, Weld LH, Barnett ED, So H, Coyle C, Greenaway C, et al. Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 2: migrants resettled internationally and evaluated for specific health concerns. Clin Infect Dis. 2013;56(7):925-33.  https://doi.org/10.1093/cid/cis1016  PMID: 23223602 
  11. Caritas and Migrantes. XXIV Rapporto Immigrazione 2014. [XXIV report on immigration 2014]. Rome: Caritas and Migrantes; June 2015. p.1-25. Italian. [Accessed 22 Aug 2015]. Available from: http://www.caritasitaliana.it/materiali//Pubblicazioni/libri_2015/Rapporto_Immigrazione/sintesi_rapportoimmigrazione2014_quadroregionale.pdf
  12. Walker PF, Jaranson J. Refugee and immigrant health care. Med Clin North Am. 1999;83(4):1103-20, viii. PMID: 10453265 
  13. Determinazione 20 marzo 2008. Linee guida per la classificazione e conduzione degli studi osservazionali sui farmaci. (GU Serie Generale n.76 del 31-3-2008). [Definition 20 March 2008.Guideline for the classification and managing of observational studies on drugs]. Gazzetta ufficiale della Repubblica Italiana. [Official Gazette of the Italian Republic]. 31 Mar 2008. Number 76. [Accessed 22 Aug 2015]. Italy. Available from: http://www.gazzettaufficiale.it/eli/id/2008/03/31/08A02109/sg
  14. Sagnelli C, Ciccozzi M, Pisaturo M, Lo Presti A, Cella E, Coppola N, et al. The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy.The impact of viral molecular diversity on the clinical presentation and outcome of acute hepatitis B in Italy. New Microbiol. 2015;38(2):137-47. PMID: 25915056 
  15. Sagnelli E, Pisaturo M, Stanzione M, Messina V, Alessio L, Sagnelli C, et al. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C. Clin Gastroenterol Hepatol. 2013;11(9):1174-1180.e11.  https://doi.org/10.1016/j.cgh.2013.03.025  PMID: 23591280 
  16. Sagnelli E, Imparato M, Coppola N, Pisapia R, Sagnelli C, Messina V, et al. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. J Med Virol. 2008;80(9):1547-53.  https://doi.org/10.1002/jmv.21239  PMID: 18649338 
  17. Coppola N, Pisapia R, Tonziello G, Masiello A, Martini S, Pisaturo M, et al. Improvement in the aetiological diagnosis of acute hepatitis C: a diagnostic protocol based on the anti-HCV-IgM titre and IgG Avidity Index. J Clin Virol. 2009;46(3):222-9.  https://doi.org/10.1016/j.jcv.2009.08.009  PMID: 19758839 
  18. Sagnelli C, Ciccozzi M, Pisaturo M, Zehender G, Lo Presti A, Alessio L, et al. Molecular epidemiology of hepatitis B virus genotypes circulating in acute hepatitis B patients in the Campania region. J Med Virol. 2014;86(10):1683-93.  https://doi.org/10.1002/jmv.24005  PMID: 24980631 
  19. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30(12):2212-9.  https://doi.org/10.1016/j.vaccine.2011.12.116  PMID: 22273662 
  20. Chevaliez S. Virological tools to diagnose and monitor hepatitis C virus infection. Clin Microbiol Infect. 2011;17(2):116-21.  https://doi.org/10.1111/j.1469-0691.2010.03418.x  PMID: 21054664 
  21. Sagnelli E, Sagnelli C, Pisaturo M, Coppola N.Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection.. Hepatic flares in chronic hepatitis C: spontaneous exacerbation vs hepatotropic viruses superinfection. World J Gastroenterol. 2014;20(22):6707-15.  https://doi.org/10.3748/wjg.v20.i22.6707  PMID: 24944463 
  22. Stornaiuolo G, Cuniato V, Cuomo G, Nocera E, Brancaccio G, De Rosa M, et al. Active recruitment strategy in disadvantaged immigrant populations improves the identification of human immunodeficiency but not of hepatitis B or C virus infections. Dig Liver Dis. 2014;46(1):62-6.  https://doi.org/10.1016/j.dld.2013.08.126  PMID: 24148806 
  23. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1-20. PMID: 18802412 
  24. Majori S, Baldo V, Tommasi I, Malizia M, Floreani A, Monteiro G, et al. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy). J Travel Med. 2008;15(5):323-7.  https://doi.org/10.1111/j.1708-8305.2008.00230.x  PMID: 19006505 
  25. Tafuri S, Prato R, Martinelli D, Melpignano L, De Palma M, Quarto M, et al. Prevalence of Hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy. BMC Infect Dis. 2010;10:213. doi: 10.1186/1471-2334-10-213
  26. Chironna M, Germinario C, Lopalco PL, Quarto M, Barbuti S. HBV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region). Epidemiol Infect. 2000;125(1):163-7.  https://doi.org/10.1017/S0950268899004215  PMID: 11057972 
  27. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Quarto M. Prevalence of hepatitis virus infections in Kosovar refugees. Int J Infect Dis. 2001;5(4):209-13.  https://doi.org/10.1016/S1201-9712(01)90073-6  PMID: 11953219 
  28. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Barbuti S, Quarto M. Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection. 2003;31(2):70-4.  https://doi.org/10.1007/s15010-002-3100-3  PMID: 12682810 
  29. Palumbo E, Scotto G, Faleo G, Cibelli DC, Saracino A, Angarano G. Prevalence of HBV-genotypes in immigrants affected by HBV-related chronic active hepatitis. Arq Gastroenterol. 2007;44(1):54-7.  https://doi.org/10.1590/S0004-28032007000100012  PMID: 17639184 
  30. Sagnelli E, Sagnelli C, Pisaturo M, Macera M, Coppola N. Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy. World J Gastroenterol. 2014;20(24):7635-43.  https://doi.org/10.3748/wjg.v20.i24.7635  PMID: 24976701 
  31. World Health Organization (WHO). Global Health Observatory (GHO) data. HIV/AIDS prevalence in sub-Saharan Africa. Geneva: WHO. [Accessed 22 Aug 2015]. Available from: http://www.who.int/gho/urban_health/outcomes/hiv_prevalence_text/en/
  32. Zanetti AR, Tanzi E, Romanò L, Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine. 1993;11(5):521-4.  https://doi.org/10.1016/0264-410X(93)90222-J  PMID: 8488702 
  33. Federal Ministry of Health, Department of Public Health, National AIDS/STDs Control Programme. Technical report. 2010 national HIV sero-prevalence sentinel survey. Abuja: Federal Ministry of Health. [Accessed 1 Sep 2015]. Available from: http://www.nigeria-aids.org/documents/2010_National%20HIV%20Sero%20Prevalence%20Sentinel%20Survey.pdf
  34. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ. 2010;88(11):847-53. doi: 10.2471/BLT.10.076349.
  35. Bonanni P, Pesavento G, Bechini A, Tiscione E, Mannelli F, Benucci C, et al. Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. Vaccine. 2003;21(7-8):685-91.  https://doi.org/10.1016/S0264-410X(02)00580-7  PMID: 12531340 
  36. Da Villa G, Sepe A. Immunization programme against hepatitis B virus infection in Italy: cost-effectiveness. Vaccine. 1999;17(13-14):1734-8.  https://doi.org/10.1016/S0264-410X(98)00414-9  PMID: 10194831 
  37. Hennessey K, Mendoza-Aldana J, Bayutas B, Lorenzo-Mariano KM, Diorditsa S. Hepatitis B control in the World Health Organization’s Western Pacific Region: targets, strategies, status. Vaccine. 2013;31(Suppl 9):J85-92.  https://doi.org/10.1016/j.vaccine.2012.10.082  PMID: 24331026 
  38. Hladun O, Grau A, Esteban E, Jansà JM. Results from screening immigrants of low-income countries: data from a public primary health care. J Travel Med. 2014;21(2):92-8.  https://doi.org/10.1111/jtm.12083  PMID: 24571720 
  39. Papadakis G, Okoba NA, Nicolaou C, Boufidou F, Ioannidis A, Bersimis S, et al. Serologic markers for HBV, HCV and HIV in immigrants visiting the Athens’ polyclinic of ‘Doctors of the World - Greece’. Public Health. 2013;127(11):1045-7.  https://doi.org/10.1016/j.puhe.2013.08.001  PMID: 24238081 
/content/10.2807/1560-7917.ES.2015.20.35.30009
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error